Jose Osorio Filho, MD
Clinical Cardiac Electrophysiology · Miami, FLNPI 1821201690
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $847,325 of the $1,223,380 with a category attached, or 69.3%. 27 manufacturers reported payments, led by Medical Device Business Services, Inc. at 40.9% of the total. Reporting peaked in 2019 at $219,976 and has fallen 62.6% since, to $82,332 in 2025. Among clinical cardiac electrophysiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,358 payments — averaging $900.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$501K
- Boston Scientific$333K
- Biosense Webster, Inc.$244K
- Abbott$63K
- Medtronic$38K
- Volta Medical Inc$26K
- plus $17K from 21 others
Across 1,238 payments — averaging $11,874 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biosense Webster, Inc.$12.5M
- Medical Device Business Services, Inc.$1.2M
- Boston Scientific$724K
- Adagio Medical, Inc.$103K
- Medtronic$88K
- Abbott$48K
- plus $75K from 2 others
Across 2 payments — averaging $231,241 each. An ownership or investment interest held by the physician or an immediate family member.
- Corvista Health, Inc.$462K
What the payments were for
- Consulting fees$847,32569%
- Speaking & faculty fees$218,81718%
- Travel & lodging$114,6099%
- Food & beverage$42,5913%
- Education$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 227 | $500,858 |
| Boston Scientific | 342 | $333,380 |
| Biosense Webster, Inc. | 431 | $244,427 |
| Abbott | 134 | $62,829 |
| Medtronic(2 entities) | 88 | $38,213 |
| Volta Medical Inc | 24 | $26,392 |
| Philips North America LLC | 8 | $5,383 |
| E.r. Squibb & Sons, L.L.C. | 6 | $4,651 |
| Siemens Medical Solutions USA, Inc. | 3 | $3,197 |
| Acutus Medical, Inc. | 26 | $2,082 |
| Atricure, Inc. | 7 | $497 |
| Novartis | 16 | $295 |
| Irhythm Technologies, Inc. | 4 | $219 |
| Biotronik Inc. | 2 | $173 |
| Johnson & Johnson | 7 | $163 |
| Pfizer | 6 | $112 |
| Amgen | 8 | $100 |
| Impulse Dynamics (USA) Inc. | 4 | $93 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $78 |
| Sanofi-aventis U.S. LLC | 3 | $55 |
| Innovation Technologies Inc | 1 | $49 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Novo Nordisk | 2 | $24 |
| Genentech USA, Inc. | 1 | $24 |
| Vektor Medical Inc. | 1 | $23 |
| Cardiva Medical, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$376,430
- Carto 3$357,321
- Watchman$47,150
- Farapulse$37,843
- ENSITE$37,832
- GENERAL - THERAPIES$27,546
- VX1$26,028
- WATCHMAN Access System$20,883
- ENSITE PRECISION$12,908
- WATCHMAN FLX$8,464
- Carto Smarttouch$7,220
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$7,188
- Spectranetics Undiv$5,000
- CLINICAL TRIAL PRODUCT$3,750
- ACUSON SC2000 Diagnostic Ultrasound System$3,000
- Thermocool SF$2,735
- DiamondTemp$1,777
- GALLANT$552
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$459
- Electrophysiology Cable$349
How this compares
$1,223,380 in reported general payments places this provider in the 95th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 134 | $114,579 |
| XareltoRivaroxaban | 30 | $29,742 |
| EntrestoSacubitril/Valsartan | 14 | $13,654 |
| Amiodarone Hcl | 22 | $1,256 |
| Flecainide Acetate | 15 | $791 |
| Metoprolol Succinate | 28 | $403 |
| Nadolol | 20 | $341 |
| Carvedilol | 42 | $210 |
| Losartan Potassium | 18 | $184 |
| Lisinopril | 21 | $114 |
| Furosemide | 18 | $52 |
| Metoprolol Tartrate | 15 | $50 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $112 | $114,579134 claims |
| Johnson & JohnsonXarelto | $163 | $29,74230 claims |
| NovartisEntresto | $295 | $13,65414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Miami
- Ivan MendozaMiami$122K
- Litsa LambrakosMiami$102K
- Mario PascualMiami$94K
- Fernando MeraMiami$82K
- Ricardo HernandezMiami$60K
- Usman SiddiquiWinter Park$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.